AWH Aspira Women's Health Inc. Insider Trading

10% Owner Jack W Schuler buys 222,222 shares of AWHL at $0.45; stock down 39.4% from 52-week high, revenue collapsed 91.4% YoY.

Jack W Schuler, a 10% owner, purchased 222,222 shares at $0.45 on 2026-06-05, increasing his non-derivative holdings to 4,046,051 shares. The purchase occurs with the stock trading at $0.43, down 39.4% from its 52-week high of $0.71, and the company facing severe operational headwinds: revenue contracted 91.4% year-over-year to $32,000.00 in the latest quarter, and the company posted negative full-year net income despite a recent quarterly profit of $676,000.00. His prior buy at this ticker on 2025-09-17 saw a 90-day return of -20.0%, and he maintains 300,000 warrant shares through his living trust, keeping his overall economic exposure intact. The timing and magnitude of this purchase against deteriorating fundamentals and depressed valuation warrant careful investor examination of whether this reflects conviction or other undisclosed circumstances.

10% Owner Schuler purchases 1,111,111 shares of AWHL at $0.45; holds 3,823,829 post-transaction; cluster pattern with 2 other insiders.

Jack W. Schuler, a 10% owner of Aspira Women's Health Inc., acquired 1,111,111 shares at $0.45 on 2025-09-17 for $499,999.95, increasing his shareholding from 2,712,718 to 3,823,829 shares (a +41.0% increase in pre-transaction holdings). His cross-ticker track record shows 16 prior buys with an average 90-day return of +1496.5% and an 85.71% win rate across all holdings, but the current price of $0.43 (down 37.7% from the 52-week high of $0.69) reflects substantial recent volatility. The company faces material headwinds: latest quarterly revenue of $169,000.00 with a net loss of $2,666,000.00, full-year net income was negative, and annual revenue has contracted 56.3%. This buy occurs within a cluster pattern—2 other insiders purchased within the past 14 days—which may signal coordinated conviction or operational positioning, though the fundamental trajectory (negative profitability, severe revenue decline) contrasts sharply with Schuler's historical buy success across other securities.

Director Fraser bought 16,389 shares of AWHL at $0.45; 3rd insider purchase in 14 days as company burns $2.7M annually.

Fraser John D, a director, purchased 16,389 shares at $0.45 per share on 2025-09-17, increasing his holdings by 3.0% to 566,393 shares. This transaction is part of a cluster pattern, with 2 other insiders also buying within the past 14 days. The timing is noteworthy given the company's severe financial deterioration: net income was $-2.7M over the most recent full fiscal year, latest quarterly revenue stands at $169,000.00, and annual revenue growth shows a -56.3% decline. The stock currently trades at $0.43, down 37.7% from its 52-week high of $0.69. Multiple insider purchases at distressed valuations amid deteriorating fundamentals and negative cash burn warrant close attention to whether insiders possess non-public information about stabilization or strategic developments.

Director Jeffrey K Cohen buys 55,556 shares of AWHL at $0.45; clusters with 2 other insider buys in 14 days amid 56.3% revenue decline

Director Jeffrey K Cohen purchased 55,556 shares at $0.45 on 2025-09-17, increasing his holdings by 17.4% to 375,697 shares. This purchase is part of a cluster pattern, with 2 other insiders also buying within the past 14 days, suggesting coordinated or independently-motivated accumulation despite significant operational headwinds. Aspira Women's Health is unprofitable (net income $-2.7M), with revenue declining 56.3% year-over-year and only $169.0K in latest quarterly revenue, while the company trades at a $15.3M market cap. The stock is currently down 37.7% from its 52-week high of $0.69, though it has risen 160.6% over 90 days and 9.5% over 30 days from lower levels. The insider transaction at $0.45 coupled with the recent cluster buy activity occurs against a backdrop of severe financial stress and depressed valuation, warranting scrutiny of management's confidence in potential turnaround prospects.

10% Owner Schuler buys 6.5K shares of unprofitable AWH; stock down -79.3% from high, insider's prior AWH buy in Jan 2024 returned -38.0% in 90d.

Schuler, a 10% owner, acquired 6,536 shares on 2024-07-09 at an undisclosed price, increasing his holdings from 0 to 6,536 shares. The stock is currently trading at $1.27, down -79.3% from its 52-week high and -63.2% over 90 days. Aspira Women's Health reported $2.2M in quarterly revenue against a $-4.6M net loss, underscoring fundamental weakness. Schuler's same-ticker history at AWH is mixed: his January 2024 buy returned -38.0% over 90 days, while his July 2023 buy returned +110.6%, suggesting inconsistent execution at this specific company. While his cross-ticker track record shows strong returns (avg 90d return +966.0%, 83.33% win rate), that broad success has not translated to AWH; investors should note the material divergence between his general track record and this ticker's outcomes.

10% owner SCHULER JACK W purchased 28,500 shares of AWH (1.5% holdings increase) amid -73.2% decline from 52-week high

Jack W. Schuler, a 10% owner, purchased 28,500 shares on 2024-01-26, increasing his holdings from 1,883,656 to 1,912,156 shares. The stock has declined significantly: -73.2% from its 52-week high of $6.13 and -38.4% over the prior 30 days. Schuler's cross-ticker track record shows strong historical returns (avg 90d return +1166.8%), and his one prior AWH transaction (buy on 2023-07-24) also proved well-timed with a 90d return of +110.6%. However, this purchase occurs in the context of fundamental weakness: Aspira Women's Health reported $2.2M in quarterly revenue against a -$4.6M net loss, with the company unprofitable over its most recent full fiscal year. The buying pattern aligns with his historical accuracy, but the stock's severe downward momentum and the company's ongoing losses present significant headwinds.